Roluperidone has been de-risked by consistent positive results in two prior pivotal trials and remains the only late-stage drug candidate for ...

Roluperidone has been de-risked by consistent positive results in two prior pivotal trials and remains the only late-stage drug candidate for this high-need population Efficacy topline data expected ...

At 67, Dr Retha Smit earns her PhD in psychiatry from Stellenbosch University, showcasing that perseverance and lifelong ...

The first duty of the state is to keep its citizens safe. In Nottingham in June 2023, it failed catastrophically. By the time ...

Bad news for some cannabis users: both recreational and medical cannabis use seem to be ineffective in reducing the symptoms ...

Drugs and alcohol can trigger, intensify, and complicate a disorder already shaped by genetics and brain chemistry ...

Four reviews on digital mental health engagement reveal critically inconsistent definitions and a shared finding: human ...

Expanding eligibility for full LIS to include those with incomes between 135-150% of the FPL is associated with a reduction in medication nonadherence.

Methylphenidate, the most commonly prescribed treatment for ADHD, is not linked with increased psychosis risk and may even be ...

A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of ...

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide, and is notoriously difficult to ...